Evidence map›Paper›PMID 36233614›Full record

ArticleJournal of clinical medicine2022

Expression of p11 in Patients with Depression.

Małgorzata Gałecka, Katarzyna Bliźniewska-Kowalska, Piotr Gałecki, Janusz Szemraj, Agata Orzechowska

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Brain-Biomarker Changes in Body Fluids of Patients with Parkinson's Disease.International journal of molecular sciences · 2023
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Małgorzata GałeckaDepartment of Psychotherapy, Medical University of Lodz, 91-229 Lodz, Poland.ORCID 0000-0002-4312-5255
Katarzyna Bliźniewska-KowalskaDepartment of Adult Psychiatry, Medical University of Lodz, 91-229 Lodz, Poland.ORCID 0000-0002-9779-7057
Piotr GałeckiDepartment of Adult Psychiatry, Medical University of Lodz, 91-229 Lodz, Poland.ORCID 0000-0003-2447-5636
Janusz SzemrajDepartment of Medical Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland.ORCID 0000-0001-6052-3557
Agata OrzechowskaDepartment of Adult Psychiatry, Medical University of Lodz, 91-229 Lodz, Poland.ORCID 0000-0003-2493-3959
Medical University of Lodz · PL

Funding

Medical University of Lodz 503/1-062-03/503-11-001-19-00Medical University of Lodz 503/5-062-02/503-51-001-19-00
6 · The paper itself

Abstract

(1) Background: Some studies suggest that the p11 protein, belonging to the so-called S100 family and located, i.a., in the nucleus accumbens of the brain, is responsible for the occurrence of depression. This protein is encoded by the S100A10 gene. The aim of our study was to evaluate the expression of the S100A10 gene at the mRNA and protein levels in patients with depressive disorders and to determine the impact of p11 in the etiopathogenesis of depression; (2) Methods: A total of 290 people (190 depressed patients, 100 healthy controls) participated in the study. Socio-demographic and clinical data were collected. The severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale (HDRS). Venous blood was collected from all participants. RT-PCR was used to evaluate gene expression at the mRNA level, while enzyme-linked immunosorbent assay (ELISA) was used to evaluate gene expression at the protein level; (3) Results: The results indicate slightly increased S100A10 gene expression (both at the protein and mRNA levels) in patients with depression, but these values do not reach statistical significance; (4) Conclusions: Due to the fact that the study was limited by the participation of patients already undergoing antidepressant treatment, its results may confirm that pharmacological treatment affecting serotonin neurotransmission is effective in upregulation of p11 in patients with depression.

Indexed as

depressiongene expressionp11

Identifiers

PMID36233614
PMCPMC9570916
OpenAlexW4297477477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.